Abstract:The major targets of current drugs used in mental health, such as neurotransmitter receptors and transporters, are based on serendipitous findings from several decades ago, and there is currently a severe drought of new drug targets. There is a pressing need for novel drugs, and much hope has been placed on the use of molecular genetics to help define them. However, despite evidence for a genetic basis to schizophrenia stretching back for over a century, and a heritability of about 80%, the identification of susceptibility genes has been an uphill struggle. Candidate gene studies, which have generally focussed on obvious candidates from the dopamine and serotonin systems, as well as genes involved in brain development, have not generally been successful, although meta-analysis indicates that the dopamine D3 receptor gene (DRD3) and the serotonin receptor gene type 2A (HTR2A) may have a very small influence on risk. Linkage analysis has provided robust evidence of genetic loci, for example, on chromosomes 8p, 13q and 22q, and also implies shared genetic aetiology with bipolar disorder. The identification of these loci together with advances in genetic technology, especially the characterisation of polymorphisms, the understanding of haplotypes and the development of statistical methods, has lead to the identification of several plausible susceptibility genes, including neuregulin 1, proline dehydrogenase and dysbindin. Interestingly, these genes point more towards a role for the glutamate pathway rather than the dopamine pathway in schizophrenia. We have attempted to replicate some of these findings in schizophrenic patients from SW China, and we find significant association with a novel neuregulin 1 haplotype, with proline dehydrogenase polymorphisms, but not with catechol-O-methyltransferase (COMT). The replication of neuregulin 1 association on chromosome 8p by several investigators is the most convincing to date, and the presence of a syndrome similar to dementia praecox of 8p linked families, and the lack of linkage of bipolar disorder to this region is a testament to the ideas of Kraepelin more than 100 years ago.

Association Analysis of Polymorphisms in the Upstream Region of the Human Dopamine D4 Receptor Gene in Schizophrenia.

The Relationship Between Drd2 Gene Polymorphisms (c957t and C939t) and Schizophrenia: A Meta-Analysis

Significant Linkage and Association Between a Functional (gt)n Polymorphism in Promoter of the N-methyl-D-aspartate Receptor Subunit Gene (GRIN2A) and Schizophrenia.

[Association of Schizophrenia with a Promoter Polymorphism in the Dopamine D2 Receptor Gene].

An Association Study Between Dopamine D1 Receptor Gene Polymorphisms and the Risk of Schizophrenia.

Association Between A-241G Polymorphism of Dopamine D_2 Receptor Promoter Gene and Schizophrenia in Chinese

Association study of polymorphisms in the promoter region of DRD4 with schizophrenia, depression, and heroin addiction

No association between schizophrenia and homozygosity at the D3 dopamine receptor gene.

[Association Analysis Between Dopamine D1 Receptor Gene and Symptom Quantitative Trait of Schizophrenia].

[Schizophrenia and Dopamine D4 Gene Polymorphism in Chinese Population: Association Analysis].

No association between alleles or genotypes at the dopamine transporter gene and schizophrenia.

Association of a Promoter Polymorphism in the Dopamine Receptor D_2 Gene in Han Population with Schizophrenia

The genetics of schizophrenia: glutamate not dopamine?

Functional-141c Ins/Del Polymorphism in the Dopamine D2 Receptor Gene Promoter and Schizophrenia in A Chinese Han Population

Meta-Analysis of Genome Wide Association Studies Showed Polymorphisms on 2P16.1, 6P22.1 and 10Q24.32 Associated with Schizophrenia in Chinese Han Population

[Associations Between Six Functional Genes and Schizophrenia].

Association Study of Dopamine Receptor Genes Polymorphisms with the Risk of Schizophrenia in the Han Chinese Population

The Ser9gly Polymorphism of the Dopamine D3 Receptor Gene and Risk of Schizophrenia: an Association Study and A Large Meta-Analysis

No Genetic Association Between Dopamine D1 Receptor Gene and [early Onset] Schizophrenia

Associations Between Dopamine D2 Receptor Gene Polymorphisms and Schizophrenia Risk: a PRISMA Compliant Meta-Analysis.

Converging Evidence Implicates the Dopamine D3 Receptor Gene in Vulnerability to Schizophrenia